Allied Market Research

Electric Vehicle Chargers Market to Reach $1,786 Billion, Globally, by 2023

LogoAsia-Pacific is expected to lead the global electric vehicle chargers market throughout the forecast period, followed by North America. LAMEA is expected to grow at a lowest rate during the forecast period. Furthermore, China dominates the electric vehicle chargers market in Asia-Pacific, similarly, the U.S. dominates the electric vehicle charger market in North America and UK leads the electric vehicle chargers market in European region.

Top Winning Strategies for Coating Resins Market by 2025

LogoThe global coating resins market was valued at $35,101 million in 2017 and is projected to reach $52,901 million by 2025.

Key Growth Factors of Artificial Vital Organs and Medical Bionics Market

LogoHealthcare technology is growing rapidly in which organ transplantation has evolved as common practice. There is a high demand from the patients for organ transplantation surgery, whereas availability of the donors to fulfill this demand is low. Due to this wider gap, artificial vital organs and medical bionics market is experiencing fair growth. The report provides an in-depth analysis of the different segments for artificial vital organs and medical bionics market and comprehensively determines the factors responsible for growth, major constraints and potential opportunities. Through analysis of leading company profiles and their strategies, professionals would gain the competitive edge in the market.

Diabetes Management Market Boosting Revenue Size in Near Future

LogoThis condition specifically results in polyuria, increase in thrust and hunger. There is high prevalence of type II diabetes worldwide due to increased obesity, urbanization, poor diet and substandard healthcare conditions. The global market for diabetes is highly lucrative for drug and device manufacturers as treatment majorly demands therapeutic and diagnostic management. Global diabetes management market is growing with high CAGR and expected to continue this trend for the forecast period. The report addresses the key themes such as market segmentation and competitive landscape. This report is investigative towards trends, opportunities and challenges present at current marketplace for diabetes management and it also provides ample information therein. In-depth analysis of market dynamics coupled with upcoming trends would be beneficial to professionals. The report would contain detailed information of key leaders with their business share.

Driveline Additives Market to Generate Huge Revenue in 2023

LogoDriveline Additives Market Report, published by Allied Market Research, forecast that the global market was valued at $4,296 million in 2016, and is estimated to reach $6,097 million by 2023, registering a CAGR of 5.2% from 2017 to 2023. In 2016, based on vehicle type, the passenger vehicles segment accounted for around two-thirds share of the total market.

Current Trends and Future Growth of Europe Nanomaterials Market

LogoEurope Nanomaterials Market by Type of Material (Carbon based, Metal & Non-metal Oxides, Metals, Dendrimers, Nanoclay, and Nanocellulose), End User (Paints & Coatings, Adhesives & Sealants) is expected to grow a with CAGR of 20.0% from 2016 to 2022, to reach $9,078 million by 2022, according to a new report by published by Allied Market Research. Metal & non-metal oxides segment is expected to remain the highest revenue-generating segment throughout the forecast period. Germany held the leading position in the European market in 2015, and is expected to maintain its lead throughout the study period.

Large Volume Parenteral (LVP) Market to Generate Huge Revenue in 2023

LogoParenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use. The factors driving this market include increasing hospitalization rate and rise in demand for faster, safer and effective administration of drugs. The introduction of single dosage nervous system disorders, oncology and diabetes would provide opportunities for growth of this market.

Foam Bags Market Opportunity Analysis and Industry Forecast, 2017-2023

LogoThey provide reliable and long-lasting protection from dust and moisture. Foam bags prove to be beneficial among food and pharmaceutical companies as one of the popular packaging solutions. This has led to attention of brand owners towards light weight packaging methods as it deliberately reduces the carriage cost of the product.

Antifungal Drugs Market Research Report 2018: Industry, Growth, Demand, Analysis and Forecast to 2023

LogoAntifungal Drugs Market by Drug type, Infection type, Indication, and Dosage Forms: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global antifungal drugs market was valued at $13,719 million in 2016, and is projected to reach $17,718 million by 2023, growing at a CAGR of 3.7% from 2017 to 2023. The azoles drug segment accounted for nearly three-eighths share of the total market in 2016.

Key Market Growth Noninvasive Cancer Diagnostics and Technologies

LogoNon-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The Noninvasive Cancer Diagnostics and Technologies Market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. Commercialization of non-invasive cancer diagnosis is possible due to completion of Human Genome Project (HGP) that gives enormous diagnostic information based on genomic and proteomic. Increase in stringent regulatory guidelines and cost associated with diagnostics is hindering the growth of non-invasive cancer diagnostic market. The Ovarian Cancer National Alliance regulations for monitoring non-invasive diagnostics are issued by FDA, Medicare and Medicaid Services (CMS) and Social Security Administration (SSA).